Clinical trials
ST-segment Elevation Myocardial Infarction (STEMI) clinical trials
Below are recruiting st-segment elevation myocardial infarction (stemi) clinical trials, each written for real people, not researchers. We’re tracking 55 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07077057Recruiting
AI tool for heart attack detection
This trial tests an artificial intelligence system that helps doctors quickly identify heart attacks (myocardial infarction) in patients with symptoms like chest pain or shortness of breath. It aims to speed up diagnosis and treatment.
Lugano, Canton TicinoAges 18 years+ - NCT07072858Recruiting
Heart MRI to Predict Recovery After Heart Attack
This study is testing if a special heart MRI taken within a week of a STEMI heart attack can help doctors predict your recovery and future risks. It may help tailor your follow-up care.
BeijingAges 18–80 - NCT07058857Recruiting
Ear stimulation test for heart attack recovery
This study tests whether gentle electrical stimulation on the tragus (small bump near your ear opening) can improve heart function in people having a first heart attack. This treatment is non-invasive and could help protect your heart from damage.
Semarang, Central of JavaAges 18–75 - NCT06967194Recruiting
Early beta blocker use after heart attack with fast heart rate or low blood pressure
This trial is testing whether giving a beta-blocker medication (metoprolol) early after a heart attack can help people who have a fast heart rate or low blood pressure but no signs of organ failure. The goal is to see if this treatment improves recovery.
Tel AvivAges 18 years+ - NCT06885619Recruiting
Predicting heart outcomes after a first heart attack with blood tests
This study looks at blood tests and heart function after a first heart attack (STEMI) treated with emergency stenting. Researchers want to see if certain molecules in the blood can predict future heart problems.
Beijing, Beijing MunicipalityAges 18–80 - NCT06769256RecruitingPhase 4
TNK vs tirofiban for heart attack with large clot
This trial tests a clot-busting drug (TNK) versus a blood thinner (tirofiban) in people having a major heart attack with a large clot. If you qualify, you would get the medicine directly into your heart artery through a thin tube to see which works better.
Zhengzhou, HenanAges 18–75 - NCT06742125Recruiting
Drug balloon vs. stent for heart attack treatment
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
Hangzhou, ZhejiangAges 18 years+ - NCT06654453Recruiting
Blood clot removal during heart attack treatment
This trial tests whether removing the blood clot from the heart artery during a stent procedure can improve outcomes for people having a heart attack. If you fit the criteria, you may be randomly assigned to receive this extra clot-removal step or the standard stent procedure alone.
Changsha, HunanAges Any age - NCT06548204RecruitingPhase 2
Antihistamine after a heart attack
This trial tests whether taking an antihistamine medicine called fexofenadine hydrochloride can help people recover better after a heart attack. It is a randomized study, so some participants will receive the medicine and others will receive a placebo (a pill with no active ingredients).
Hangzhou, ZhejiangAges 18 years+ - NCT06227754Recruiting
OCT vs. angiography for heart attack treatment
This trial compares two ways to guide treatment during a heart attack: using a special camera (OCT) inside the artery or standard X-ray (angiography). It aims to see which method leads to better results for patients.
Daegu, DaeguAges 19 years+ - NCT06174753RecruitingPhase 3
Dapagliflozin for large heart attacks (STEMI)
This trial tests whether a diabetes drug called dapagliflozin can help people recover from a major heart attack (STEMI). You may qualify if you had a large heart attack within the last 12 hours and have not had a heart attack before.
Ottawa, OntarioAges 18 years+ - NCT05920629Recruiting
Moderate drinking and heart recovery after a recent heart attack
This study looks at whether moderate alcohol intake affects heart function after a recent heart attack. You may be asked to follow a specific plan and attend scheduled visits so researchers can measure changes in your heart and overall recovery.
Basel, BaselAges 18 years+ - NCT05892042Recruiting
Anticoagulant treatment for a heart clot after a heart attack
This trial studies whether a specific blood thinner can better treat a left-side heart clot found soon after a heart attack. It may help prevent the clot from getting worse or causing complications.
Changchun, JilinAges 18–80 - NCT05669222Recruiting
Staged procedure after heart attack using two heart-visual tests
This trial studies whether doing a planned, staged treatment for some artery blockages after a heart attack can improve outcomes. It uses detailed images of the heart arteries and compares results in people who are stable after their initial emergency procedure.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05211401RecruitingPhase 2
Testing rituximab for heart attack patients
This study tests whether adding the drug rituximab to standard heart attack treatment can reduce damage to the heart muscle after a heart attack. Rituximab is usually used for immune system conditions, and it may help calm inflammation and protect the heart. Participants must have a certain type of heart attack and be treated quickly.
ParisAges 18 years+ - NCT04939805Recruiting
Blood-cleaning treatment after first heart attack
This trial tests whether a blood-cleaning procedure called CRP apheresis, given after a first heart attack, can improve recovery when a heart-attack blood marker (CRP) is high. It’s aimed at people whose heart attack is treated quickly with a procedure to open blocked arteries, and who are well enough for heart MRI scans.
GrazAges 18–85 - NCT04775914Recruiting
Test a heart procedure guide during emergency STEMI treatment
This trial studies whether adding a special heart “reset” step (ischemic postconditioning) and using an imaging guide during the emergency procedure can improve outcomes for people having a STEMI heart attack. It’s meant to optimize treatment when a blocked heart artery is being opened.
Copenhagen, Capital RegionAges 18 years+ - NCT04212494Recruiting
Aspirating clot during heart procedure for certain heart attacks
This trial studies whether removing (“aspirating”) a blood clot during an emergency heart procedure works better for people having a specific type of heart attack with a large clot burden. It may help improve blood flow after treatment, but it is only for patients who meet several timing and safety conditions.
Fuzhou, FujianAges 18 years+ - NCT03539133Recruiting
Study heart-to-body communication after a heart attack
This study is for people who have recently had a STEMI heart attack. Researchers are looking at how the heart’s injury affects the rest of the body, which may help improve care after this type of emergency.
DüsseldorfAges 18 years+ - NCT03787745Recruiting
Testing a heart-protection method after a blocked-artery procedure
This study looks at whether “ischemic postconditioning” (briefly changing blood flow right after opening a blocked heart artery) can improve outcomes in people with a specific type of heart attack. It’s meant for patients who get primary PCI (a catheter-based procedure to reopen the artery) soon after symptoms start.
CopenhagenAges 18 years+ - NCT07467213RecruitingPhase 3
Acid reflux drug for heart attack recovery
This trial tests if a newer acid-reducing drug is better than standard care for preventing stomach problems in people who recently had a heart attack and a stent placed. It could help those who need stomach protection while on blood thinners.
SeoulAges 19 years+ - NCT04899479RecruitingPhase 4
SGLT-2 inhibitor after heart attack to improve heart recovery
This trial studies whether starting an SGLT-2 inhibitor around the time of a heart attack can reduce heart damage size and improve how the heart heals. It focuses on people with a high risk of developing heart failure and who are getting a procedure to open blocked heart arteries.
SeoulAges 18 years+ - NCT07252245Recruiting
Improving how emergency teams decide who needs urgent heart care
This study is testing a way to help doctors decide which patients with chest pain need immediate transfer to a cardiac emergency department. It aims to improve the process of triaging patients who might be having a heart attack.
HapsAges 18 years+ - NCT01311323Recruiting
Testing heart procedures to fully open blocked coronary arteries
This trial compares different ways to treat serious heart artery blockages in people with a recent heart attack or unstable chest pain. It aims to see which revascularization approach works best when doctors think the heart arteries can be fully treated.
Chrzanów, MalopolskaAges 18 years+
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for st-segment elevation myocardial infarction (stemi)?
- Yes. Clin2 currently lists 55 recruiting st-segment elevation myocardial infarction (stemi) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a st-segment elevation myocardial infarction (stemi) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a st-segment elevation myocardial infarction (stemi) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- STEMI - ST Elevation Myocardial Infarction
- NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
- Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
- ST Segment Elevation Myocardial Infarction
- ST Elevation Myocardial Infarction
- Non-ST Elevation Myocardial Infarction
- Acute Myocardial Infarction With ST Elevation
- Myocardial Infarction
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.